embryonic stem cells news from FierceBiotech
News
ALSO NOTED: Amgen analysts bearish; FDA hands Kyowa not-approvable letter; Valeant plans review; and much more...
> Oh, the curse of duplication. Schering-Plough embarked on a company-wide downsizing yesterday, eliminating hundreds of jobs in nearly all departments, including finance, research, information Read more...
Novocell reports breakthrough in diabetes cure
Researchers at Novocell report a key breakthrough in their program to find a cure for Read more...
ALSO NOTED: Lentigen moves to Gaithersburg; Acorda prices shares; Cytheris releases data; and much more...
> Lentigen Corporation today announced the company is moving its corporate headquarters and manufacturing facilities from the University of Maryland Baltimore County TechCenter to a new 26,000 Read more...
ALSO NOTED: Flamel shares buoyed by partnership buzz; Medarex cuts stake in Genmab; Bush offers new stem cell funds; and much m
> Shares of France's Flamel Technologies were buoyed by an analyst's prediction that the company was nearing a late-stage partnering deal. Read more...
ALSO NOTED: NMT closes trial; NovaMed raises cash; Sinovac sells shares; Genentech team advances lupus work; and much more...
> NMT Medical says it will close a trial of its migraine technology after experiencing difficulties--and high costs--enrolling patients. Read more...
Human embryo clones unveiled by CA scientists
Scientists in California made embryo clones of two men, a step toward developing new stem cells for therapeutic purposes. But a number of experts quickly noted that cloned embryos of humans have been Read more...
ALSO NOTED: Biogen snares first start-up for incubator; Alkermes gains from Reliance sale; Galapagos inks deal with Lilly; and
> Biogen Idec has announced the first "occupant" in its Biogen Idec Innovation Incubator (bi3): Escoublac, a startup founded on the discovery of a new link between bone biology and metabolism. The Read more...
ALSO NOTED: Nuvelo drug gets fast tracked; QLT brings on Goldman Sachs; and much more...
> Sanofi-Aventis has set up a small executive committee to set strategy, allocate resources and oversee company management, according to anonymous sources who talked to APM Europe. The idea is to Read more...
ALSO NOTED: ESC companies unimpressed by latest advance; Delcath shares surge in trial resumption; Pharmion CEO ready to start
> News that scientists had found a way to program skin cells to act like embryonic stem cells has failed to shake the clinical trial plans of the leading developers in the field. Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets